+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

ePharmacies - Global Strategic Business Report

  • PDF Icon

    Report

  • 242 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1882091
The global market for ePharmacies was valued at US$99.8 Billion in 2024 and is projected to reach US$229.9 Billion by 2030, growing at a CAGR of 14.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global ePharmacies Market - Key Trends & Drivers Summarized

Why Are ePharmacies Disrupting the Traditional Pharmaceutical Retail Landscape?

ePharmacies are redefining the pharmaceutical retail industry by offering a more convenient, accessible, and cost-effective way for consumers to purchase medications and healthcare products online. These digital platforms provide customers with a streamlined experience, allowing them to browse a wide range of prescription and over-the-counter (OTC) drugs, supplements, and wellness products from the comfort of their homes. The ability to place orders online and have medications delivered directly to one’s doorstep is a major advantage, particularly for patients with mobility issues, chronic conditions, or those living in remote areas without easy access to physical pharmacies. Moreover, ePharmacies often offer additional services such as online consultations, medication management, and automated refill reminders, enhancing the overall patient experience and supporting medication adherence.

The demand for ePharmacies is being fueled by several factors, including the increasing penetration of the internet and smartphones, the rising preference for online shopping, and the growing awareness of digital health solutions. Consumers today are accustomed to the convenience and speed of e-commerce, and ePharmacies are capitalizing on this trend by providing an easy-to-use platform for purchasing medications. Additionally, the COVID-19 pandemic significantly accelerated the adoption of ePharmacies, as lockdowns, social distancing measures, and concerns about visiting crowded places led many people to seek online alternatives for purchasing medications and healthcare products. This shift in consumer behavior has spurred the growth of ePharmacies globally, transforming them into a mainstream channel for pharmaceutical sales. As digital health continues to gain traction and more consumers embrace the benefits of online healthcare solutions, the ePharmacies market is poised for continued expansion, supported by evolving consumer preferences, technological advancements, and a focus on improving access to healthcare.

What Technological Advancements Are Driving the Growth and Adoption of ePharmacies?

Technological advancements are playing a pivotal role in enhancing the capabilities and reach of ePharmacies, making them more efficient, secure, and accessible for a diverse range of consumers. One of the most impactful innovations in this space is the integration of artificial intelligence (AI) and machine learning (ML) algorithms into ePharmacy platforms. AI-driven solutions are being used to analyze customer preferences, predict medication needs, and offer personalized recommendations based on a user’s medical history, lifestyle, and purchasing behavior. This level of personalization is not only improving the customer experience but also supporting better health outcomes by ensuring that patients receive timely reminders for medication refills, dosage adjustments, and potential drug interactions. Moreover, AI-powered chatbots and virtual assistants are being deployed to provide instant support and answer customer queries, enhancing engagement and satisfaction.

Another significant technological advancement is the adoption of blockchain technology to ensure the authenticity, traceability, and safety of pharmaceutical products sold through ePharmacies. Blockchain’s decentralized and immutable ledger can be used to track the entire supply chain of medications, from manufacturing and distribution to final delivery, ensuring that only genuine and unexpired drugs reach consumers. This technology is addressing one of the major concerns associated with ePharmacies - the risk of counterfeit or substandard medications - by providing transparency and trust in the supply chain. Additionally, blockchain technology can facilitate secure and confidential data exchange between healthcare providers, pharmacists, and patients, supporting compliance with data privacy regulations such as the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR).

The integration of telemedicine and telepharmacy services is further driving the growth of ePharmacies. Many ePharmacies are partnering with telehealth platforms to offer online consultations with licensed healthcare professionals, enabling patients to receive prescriptions without the need for an in-person visit. This seamless integration of telehealth and ePharmacy services is providing a comprehensive healthcare solution that includes consultation, diagnosis, prescription, and medication delivery, all through a single platform. The convenience of accessing healthcare services remotely is making ePharmacies particularly attractive to patients with busy schedules, those who live in rural areas, and individuals seeking discretion in managing sensitive health issues. Furthermore, the use of data analytics and cloud computing is enabling ePharmacies to optimize inventory management, streamline logistics, and improve operational efficiency, ensuring that medications are delivered promptly and accurately to customers.

The development of mobile health (mHealth) apps and wearable devices is also influencing the adoption of ePharmacies. Mobile apps provide users with the ability to track their health metrics, set medication reminders, and order refills directly from their smartphones. Integration with wearable devices, such as fitness trackers and smartwatches, allows ePharmacies to offer a more holistic health management solution by tracking physical activity, sleep patterns, and vital signs. These connected health technologies are enabling ePharmacies to provide more personalized and proactive healthcare support, positioning them as key players in the broader digital health ecosystem. As technology continues to evolve, ePharmacies are expected to incorporate more advanced features, such as predictive analytics, voice-enabled interfaces, and AI-powered health coaching, supporting their ongoing growth and adoption.

How Are Market Dynamics and Regulatory Standards Shaping the ePharmacies Market?

The ePharmacies market is shaped by a complex set of market dynamics, regulatory standards, and industry trends that are influencing product development, adoption, and business strategies. One of the primary market drivers is the increasing consumer preference for convenience and accessibility in healthcare services. As people become more accustomed to the ease of online shopping, they are seeking similar convenience in the healthcare sector. ePharmacies are meeting this demand by providing a user-friendly platform for purchasing medications and healthcare products, complete with home delivery options, online payment systems, and customer support services. The ability to order medications online is particularly beneficial for individuals with chronic conditions who require regular medication refills, as well as for elderly patients and caregivers who may find it challenging to visit physical pharmacies.

Regulatory standards and compliance requirements are playing a critical role in shaping the ePharmacies market, particularly with regard to ensuring patient safety, data privacy, and the legitimacy of pharmaceutical products. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regional bodies have established guidelines for the online sale of medications to prevent the distribution of counterfeit, expired, or unsafe drugs. Compliance with these regulations is essential for ePharmacies to gain market access and maintain trust among consumers. In some regions, stringent regulations may limit the types of medications that can be sold online or require ePharmacies to partner with licensed brick-and-mortar pharmacies. The regulatory landscape is evolving to address the rapid growth of the ePharmacy sector, with a focus on enhancing patient safety, ensuring data security, and facilitating the safe and efficient distribution of pharmaceuticals.

Market dynamics such as competition among ePharmacy providers, technological innovation, and changing consumer behaviors are also influencing the ePharmacies market. The competitive landscape is characterized by the presence of established online pharmacies, traditional pharmacy chains expanding their digital presence, and new entrants offering specialized services such as subscription-based medication delivery and wellness consultations. Companies are differentiating themselves through unique value propositions, such as offering same-day or express delivery, personalized health recommendations, and integrated telehealth services. Technological advancements such as AI-driven analytics, blockchain for supply chain transparency, and digital therapeutics are enabling ePharmacies to offer more comprehensive and reliable healthcare solutions. Additionally, partnerships and collaborations with healthcare providers, insurance companies, and pharmaceutical manufacturers are expanding the reach and capabilities of ePharmacies, enabling them to serve a broader customer base.

The impact of consumer behaviors and preferences is also shaping the ePharmacies market. There is a growing trend toward holistic health management, where consumers seek integrated solutions that encompass not only medications but also supplements, wellness products, and preventive healthcare services. ePharmacies are responding to this trend by expanding their product offerings to include a wider range of health and wellness products, such as vitamins, nutraceuticals, personal care items, and health monitoring devices. The integration of digital health services, such as fitness tracking, diet planning, and mental health support, is positioning ePharmacies as one-stop health platforms that cater to a variety of consumer health needs. As these market dynamics and regulatory standards continue to evolve, they are shaping the development and competitiveness of the ePharmacies market, influencing product design, business strategies, and market positioning.

What Are the Key Growth Drivers Fueling the Expansion of the ePharmacies Market?

The growth in the global ePharmacies market is driven by several key factors, including the increasing adoption of digital health technologies, the rising demand for convenience and accessibility in healthcare, and the expansion of healthcare services in emerging markets. One of the primary growth drivers is the rapid adoption of digital health technologies, which is making it easier for consumers to access healthcare services online. The proliferation of smartphones, widespread internet connectivity, and growing consumer trust in e-commerce are supporting the growth of ePharmacies by enabling users to browse, compare, and purchase medications through digital platforms. The integration of digital health services such as telemedicine, online consultations, and health tracking is enhancing the functionality and appeal of ePharmacies, positioning them as key players in the digital transformation of healthcare.

Another significant growth driver is the increasing demand for convenience and accessibility in healthcare services. As consumers seek more flexible and on-demand healthcare options, ePharmacies are providing a solution that aligns with these preferences. The ability to order medications from home, schedule deliveries, and access healthcare information online is making ePharmacies particularly appealing to patients with chronic conditions, busy professionals, and those living in rural or underserved areas. The growing acceptance of online healthcare services among elderly patients, caregivers, and individuals with mobility issues is also contributing to market growth. Additionally, the inclusion of wellness products, supplements, and personal care items in ePharmacy offerings is attracting a wider audience, supporting the expansion of the market.

The expansion of healthcare services in emerging markets is also fueling the growth of the ePharmacies market. In regions such as Asia-Pacific, Latin America, and the Middle East, the rising middle class, increasing healthcare spending, and improving internet penetration are driving the adoption of ePharmacy platforms. The need for affordable and accessible healthcare services in these regions is creating opportunities for ePharmacies to expand their presence and serve a larger customer base. Governments and healthcare organizations in emerging markets are also promoting the use of digital health technologies to improve healthcare delivery and reduce the burden on physical healthcare infrastructure. As more consumers in these regions embrace digital health solutions, the demand for ePharmacies is expected to rise, supporting the overall growth of the market.

Lastly, the increasing focus on regulatory compliance and patient safety is contributing to the growth of the ePharmacies market. As regulatory bodies establish guidelines for the online sale of medications, ePharmacies are investing in compliance management, quality assurance, and supply chain transparency to ensure patient safety and build consumer trust. The use of technologies such as blockchain, AI-driven verification systems, and secure data management solutions is helping ePharmacies meet regulatory requirements and provide a safe and reliable platform for purchasing medications. The ability to demonstrate compliance and offer a secure shopping experience is enhancing the credibility of ePharmacies, encouraging more consumers to choose online platforms for their healthcare needs. As demand from key sectors such as chronic disease management, wellness, and preventive healthcare continues to rise, and as ePharmacies innovate to meet evolving consumer needs, the global ePharmacies market is expected to witness sustained growth, driven by advancements in technology, expanding applications, and the increasing emphasis on digital health and accessibility in healthcare services.

Scope of the Study

The report analyzes the ePharmacies market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Product Type (Over-the-Counter (OTC) Drugs, Prescription Drugs).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Over-The-Counter (OTC) Drugs segment, which is expected to reach US$127.2 Billion by 2030 with a CAGR of a 13.7%. The Prescription Drugs segment is also set to grow at 16.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $33.7 Billion in 2024, and China, forecasted to grow at an impressive 20.4% CAGR to reach $34.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Apex Healthcare Berhad (Apex Pharmacy), Apollo Pharmacies Limited, Axelia Solutions Pvt. Ltd. (Pharmeasy), CVS Health Corp., DocMorris AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global ePharmacies Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global ePharmacies Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global ePharmacies Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 63 major companies featured in this ePharmacies market report include:

  • Apex Healthcare Berhad (Apex Pharmacy)
  • Apollo Pharmacies Limited
  • Axelia Solutions Pvt. Ltd. (Pharmeasy)
  • CVS Health Corp.
  • DocMorris AG
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • Netmeds
  • Optum, Inc.
  • Rowlands Pharmacy
  • Walgreens Boots Alliance Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • What’s the Current State of Global Drug Distribution?
  • ePharmacies, an Emerging Link in the Distribution System with the Promise of Closing the Gap in Modern Healthcare
  • As Global Medicine Demand Breaches the Trillion Dollar Mark, ePharmacies Role in Enabling Better Access to Medicines is Poised to Grow Bigger: Global Medicine Spending (In US$ Billion) for the Years 2022, 2024, 2026, 2028 and 2030
  • Economic Frontiers: Trends, Trials & Transformations
  • In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
  • All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
  • With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
  • Competition
  • ePharmacies - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • ePharmacies: Overview & Types
  • Influencer/Product/Technology Insights
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advanced Internet Infrastructure & Robust Smartphone Penetration Provide the Launchpad for the Rise of ePharmacies
  • Access to Internet Equals Access to e-Pharmacy Services: Global Internet Users (In Million) for Years 2018 through 2025
  • Smartphones Provide the Gateway to Access e-Pharmacies: Global Smartphones Users (In US$ Million) for Years 2024, 2026, 2028 and 2030
  • Improved Digital Payment Solutions Sustain Growth in e-Pharmacies
  • Enhanced Digital Payment Solutions Propel E-Pharmacy Sales to New Heights: Global Digital Payments Transaction Value (In US$ Trillion) for Years 2024, 2026, 2028, 2030, and 2032
  • Healthcare Challenges of an Aging Population Opens Opportunities for e-Pharmacies
  • E-Pharmacies Revolutionize Healthcare for Aging Populations, Enhancing Accessibility and Reducing Costs: Global Aging Population (Aged 65+ In Million) for Years 2024, 2040, 2050 and 2100
  • Rapid Evolution of Telemedicine Drives Demand Opportunities for e-Pharmacies Services
  • From Virtual Consultations to Doorstep Delivery, Telemedicine-E-Pharmacy Alliance is Poised to Score Big Gains in the Market: Global Telemedicine Market (In US$ Billion) for Years 2024, 2026, 2028, 2030 and 2032
  • New Opportunities Emerge With Seamless Integration of Telepharmacy With e-Pharmacies. Here’s the Story
  • Expanding Mobile Health Creates a Parallel Expansion of Opportunities for e-Pharmacies
  • Advanced mHealth Apps Spearhead the Progress and Integration of e-Pharmacy Apps: Global mHealth Apps Market (In US$ Billion) for Years 2024, 2026, 2028, 2030 and 2032
  • Rise in Chronic Diseases Expands the Addressable Market Opportunity for e-Pharmacies
  • As Disease Burden Rises so Does the Need for Medicines: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2024 and 2030
  • Growing Use of Medicines is a Clear Opportunity for e-Pharmacies to Tap Into: Global Use of Medicines (In Defined Daily Doses (DDD) in Billions) for the Years 2024, 2026 and 2028
  • Rise of AI in ePharmacies, an Exciting Trend to Watch Out For!
  • With Regulators Failing to keep Up, Illegal ePharmacies Cast a Shadow Over the Market
  • As Illegal Pharmacies Eat Away into Legal Markets & Push Up Healthcare Costs by Causing Adverse Health Events, the Need of the Hour is Strict Regulation & Control: Lost Economic Value to U.S. Healthcare Systems Due to Illegal Pharmacies (In US$ Billion) for Years 2020, 2022 and 2024
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World ePharmacies Market Analysis of Annual Sales in US$ Million for Years 2019 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 4: World 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2019, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Over-The-Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Over-The-Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 7: World 11-Year Perspective for Over-The-Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2019, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 10: World 11-Year Perspective for Prescription Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2019, 2024 & 2030
  • Recent Market Activity
III. MARKET ANALYSIS
UNITED STATES
  • TABLE 11: USA Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 12: USA Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 13: USA 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
CANADA
  • TABLE 14: Canada Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: Canada Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 16: Canada 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
JAPAN
  • TABLE 17: Japan Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Japan Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 19: Japan 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
CHINA
  • TABLE 20: China Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: China Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 22: China 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
EUROPE
  • TABLE 23: Europe Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 25: Europe 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2019, 2024 & 2030
  • TABLE 26: Europe Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 28: Europe 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
FRANCE
  • TABLE 29: France Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: France Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 31: France 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
GERMANY
  • TABLE 32: Germany Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Germany Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 34: Germany 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
ITALY
  • TABLE 35: Italy Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Italy Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 37: Italy 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
UNITED KINGDOM
  • TABLE 38: UK Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: UK Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 40: UK 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
SPAIN
  • TABLE 41: Spain Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Spain Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 43: Spain 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
RUSSIA
  • TABLE 44: Russia Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Russia Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 46: Russia 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
REST OF EUROPE
  • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Rest of Europe Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 49: Rest of Europe 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
ASIA-PACIFIC
  • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 51: Asia-Pacific Historic Review for ePharmacies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 52: Asia-Pacific 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2019, 2024 & 2030
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
AUSTRALIA
  • TABLE 56: Australia Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Australia Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 58: Australia 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
INDIA
  • TABLE 59: India Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: India Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 61: India 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
SOUTH KOREA
  • TABLE 62: South Korea Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: South Korea Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 64: South Korea 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
REST OF ASIA-PACIFIC
  • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Rest of Asia-Pacific Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 67: Rest of Asia-Pacific 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
LATIN AMERICA
  • TABLE 68: Latin America Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Latin America Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 70: Latin America 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
MIDDLE EAST
  • TABLE 71: Middle East Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Middle East Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 73: Middle East 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
AFRICA
  • TABLE 74: Africa Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Africa Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 76: Africa 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Apex Healthcare Berhad (Apex Pharmacy)
  • Apollo Pharmacies Limited
  • Axelia Solutions Pvt. Ltd. (Pharmeasy)
  • CVS Health Corp.
  • DocMorris AG
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • Netmeds
  • Optum, Inc.
  • Rowlands Pharmacy
  • Walgreens Boots Alliance Inc.

Table Information